The AICPA A&A Focus webcast on Oct. 8 continued its deep dive into practical issues shaping today’s accounting and assurance landscape. Hosted by Bob Durak, CPA, CGMA, director–A&A Technical Services ...

Ron Messenger, CEO of Grant Thornton’s audit business, is bullish on the practice’s future after a 2024 deal that sold a ...

Global technology platform Intuit recently held a virtual forum, in partnership with BusinessWorld, last Oct. 2 to tackle recent advancements in the accounting profession and to give a brief preview ...

PRINCESS ANNE, Md. - A recent audit has uncovered multiple violations and financial issues within Somerset County Public Schools according to education officials. During a Somerset County School Board ...

The Internal Auditors and Assurance Conference 2026 is a premier two-day gathering designed to equip internal audit and assurance professionals with the tools, insights, and strategies needed to ...

ST. LOUIS – The St. Louis Sheriff’s Office exceeded its 2025 fiscal year budget by nearly $1 million, according to a new city audit highlighting widespread financial mismanagement. On Tuesday, St.

Accounting practice management solutions provider Canopy announced AI-powered upgrades to its Smart Intake solution designed to propose, collect and deliver work within a single centralized solution.

Patrick James, founder and chief executive officer of US-based auto parts supplier First Brands, resigned on Monday, weeks after the company filed for bankruptcy protection amid an alleged accounting ...

Ernst and Young’s forensic examination of more than $1 billion in cashflows through the Centerra urban renewal plan has uncovered a pattern of questionable accounting practices and noncompliance with ...

About Advanced Micro Devices Inc. Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and ...

In August, Zongertinib received FDA approval for previously treated HER2-mutant NSCLC. It now shows efficacy in first-line treatment, with a 77% objective response rate and 96% disease control rate.